Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 50013704
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133573(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-phe...)
Affinity DataIC50: 900nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133557(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)
Affinity DataIC50: 1.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133579(N-(tert-butoxy)-N'-[2-(2,6-dichlorobenzyl)-1,3-thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133575(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-(te...)
Affinity DataIC50: 3.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133564(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-pyrroli...)
Affinity DataIC50: 3.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133551(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-2,2-di...)
Affinity DataIC50: 4.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133580(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-eth...)
Affinity DataIC50: 5.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133569(1-Morpholin-4-yl-3-[2-(pyridine-2-sulfonylmethyl)-...)
Affinity DataIC50: 5.00E+3nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133556(1-Morpholin-4-yl-3-(2-phenyl-thiazol-4-yl)-urea | ...)
Affinity DataIC50: 6.00E+3nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133566(N-{2-[(methylsulfonyl)methyl]-1,3-thiazol-4-yl}-N'...)
Affinity DataIC50: 6.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133555(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-piperid...)
Affinity DataIC50: 6.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133567(N-(allyloxy)-N'-[2-(2,6-dichlorobenzyl)-1,3-thiazo...)
Affinity DataIC50: 6.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133576(N-phenoxy-N'-(2-phenyl-1,3-thiazol-4-yl)urea | CHE...)
Affinity DataIC50: 8.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133549(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-met...)
Affinity DataIC50: 9.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133556(1-Morpholin-4-yl-3-(2-phenyl-thiazol-4-yl)-urea | ...)
Affinity DataIC50: 9.00E+3nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133551(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-2,2-di...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133574(1-Azepan-1-yl-3-[2-(2,6-dichloro-benzyl)-thiazol-4...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133565(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-2-meth...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133557(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133568(1-[2-(2-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133569(1-Morpholin-4-yl-3-[2-(pyridine-2-sulfonylmethyl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133559(1-Morpholin-4-yl-3-(2-thiophen-2-yl-thiazol-4-yl)-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133579(N-(tert-butoxy)-N'-[2-(2,6-dichlorobenzyl)-1,3-thi...)
Affinity DataIC50: 1.50E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133560(N-[2-(3-methylphenyl)-1,3-thiazol-4-yl]-N'-phenoxy...)
Affinity DataIC50: 1.60E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133580(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-eth...)
Affinity DataIC50: 2.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133550(1-[2-(4-Methoxy-phenoxymethyl)-thiazol-4-yl]-3-mor...)
Affinity DataIC50: 2.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133552(N-(2-benzyl-1,3-thiazol-4-yl)-N'-phenoxyurea | CHE...)
Affinity DataIC50: 2.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133553(1-Morpholin-4-yl-3-(2-m-tolyl-thiazol-4-yl)-urea |...)
Affinity DataIC50: 2.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133564(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-pyrroli...)
Affinity DataIC50: 2.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133568(1-[2-(2-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133577(1-Morpholin-4-yl-3-(2-phenylsulfanylmethyl-thiazol...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133550(1-[2-(4-Methoxy-phenoxymethyl)-thiazol-4-yl]-3-mor...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133577(1-Morpholin-4-yl-3-(2-phenylsulfanylmethyl-thiazol...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133559(1-Morpholin-4-yl-3-(2-thiophen-2-yl-thiazol-4-yl)-...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133555(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-piperid...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133553(1-Morpholin-4-yl-3-(2-m-tolyl-thiazol-4-yl)-urea |...)
Affinity DataIC50: 3.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133576(N-phenoxy-N'-(2-phenyl-1,3-thiazol-4-yl)urea | CHE...)
Affinity DataIC50: 3.50E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133567(N-(allyloxy)-N'-[2-(2,6-dichlorobenzyl)-1,3-thiazo...)
Affinity DataIC50: 4.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133554(1-(2-Benzyl-thiazol-4-yl)-3-morpholin-4-yl-urea | ...)
Affinity DataIC50: 5.50E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133565(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-2-meth...)
Affinity DataIC50: 6.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133574(1-Azepan-1-yl-3-[2-(2,6-dichloro-benzyl)-thiazol-4...)
Affinity DataIC50: 7.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133561(1-Morpholin-4-yl-3-(2-phenoxymethyl-thiazol-4-yl)-...)
Affinity DataIC50: 8.00E+4nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133575(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-(te...)
Affinity DataIC50: 9.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133566(N-{2-[(methylsulfonyl)methyl]-1,3-thiazol-4-yl}-N'...)
Affinity DataIC50: 9.00E+4nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133582(1-Morpholin-4-yl-3-(2-p-tolyl-thiazol-4-yl)-urea |...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133573(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-phe...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133563(1-(2-Ethyl-thiazol-4-yl)-3-morpholin-4-yl-urea | C...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133561(1-Morpholin-4-yl-3-(2-phenoxymethyl-thiazol-4-yl)-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Pharmacia

Curated by ChEMBL
LigandPNGBDBM50133581(1-[2-(4-Chloro-phenyl)-thiazol-4-yl]-3-morpholin-4...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit Cyclin-dependent kinase 5-p35.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50133549(N-[2-(2,6-dichlorobenzyl)-1,3-thiazol-4-yl]-N'-met...)
Affinity DataIC50: 1.00E+5nMAssay Description:Ability to inhibit cyclin-dependent kinase 2-cyclin A.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: